Efficacy and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients

Br J Dermatol. 2023 Jul 17;189(2):244-246. doi: 10.1093/bjd/ljad136.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Pemphigoid, Bullous* / drug therapy
  • Retrospective Studies

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized